MedTrace Logo

Which Taping Technique is More Effective on Balance Skills in Children With Mildly Affected Cerebral Palsy?

NCT06231108 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2025-02-07

No results posted yet for this study

Summary

"Our study aims to determine which of ankle correction, quadriceps facilitation, and gluteus maximus facilitation taping provides a better immediate effect on balance skills in children with mildly affected cerebral palsy. Children whose parents have given consent for the study will undergo three different taping applications with a one-week interval. After each taping application, a 15-minute waiting period will be observed, followed by balance assessment using the Wii Balance System with eyes open and closed."

Conditions

  • Cerebral Palsy

Interventions

OTHER

Kinesio Taping

"Three different taping applications will be applied, namely ankle correction, quadriceps facilitation, and gluteus maximus facilitation." 1. Taping: Functional correction technique will be used to facilitate dorsal flexion movement." 2. Taping: Quadriceps Femoris (QF) Facilitation Technique - In taping to activate the QF muscle and regulate muscle tone, the patient will be placed in a supine position with hips and knees in neutral. 3. Taping: Gluteus Maximus (GM) Facilitation Technique - For taping to facilitate the GM muscle, a double-band application will be performed.

Sponsors & Collaborators

  • Abant Izzet Baysal University

    lead OTHER

Principal Investigators

  • Ozge KARANLIK, Msc · Abant Izzet Baysal University

Eligibility

Min Age
4 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-21
Primary Completion
2025-06-01
Completion
2025-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231108 on ClinicalTrials.gov